These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2103252)

  • 1. [The current situation of therapy in hyperlipemias].
    Vallina Alvarez E; Arribas Castrillo JM; Suárez García E
    An Med Interna; 1990 Jul; 7(7):370-4. PubMed ID: 2103252
    [No Abstract]   [Full Text] [Related]  

  • 2. [How sure is the combined lipid lowering?].
    Schäfer J
    MMW Fortschr Med; 2005 Jan; 147(1-2):56. PubMed ID: 15704576
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hyperlipemias and hypolipemic agents].
    Scheen AJ; Paquot N
    J Pharm Belg; 1993; 48(2):92-101. PubMed ID: 8492291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs for lipid disorders.
    Treat Guidel Med Lett; 2003 Aug; 1(12):77-82. PubMed ID: 15529095
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of hyperlipidemia in diabetes.
    Vinik AI; O'Brian JT; Georges LP; Leichter SB; Janin Y
    Compr Ther; 1995 Oct; 21(10):602-9. PubMed ID: 8565431
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cost-benefit analysis of the therapy of lipid metabolism disorders].
    Karádi I
    Orv Hetil; 1996 May; 137(21):1164. PubMed ID: 8757110
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hyperlipemias : therapeutics (dietetics-medication)].
    Benoit G
    Lille Med; 1975 Apr; 20(4):381-6. PubMed ID: 1152590
    [No Abstract]   [Full Text] [Related]  

  • 8. Experience with crystalline niacin as the preferred drug for dyslipidemia in a specialty clinic.
    Rindone JP; Arriola OG
    Pharmacotherapy; 1997; 17(6):1296-9. PubMed ID: 9399614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing drug usage and adverse effects. Part III: Cardiovascular disease and hyperlipidemia.
    Baron M
    Health Care Food Nutr Focus; 2005 Jun; 22(6):7-11. PubMed ID: 15923907
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current therapeutic trends in hyperlipemia].
    Policlinico Prat; 1970 Feb; 77(5):158-64. PubMed ID: 5436072
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug therapy of hyperlipidemias].
    Wolfram G
    Wien Med Wochenschr; 1981; 131(13-14):333-8. PubMed ID: 7281700
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug therapy of dyslipidemias].
    Fonda M; Cattin L; Guarnieri G
    Recenti Prog Med; 2000; 91(7-8):375-8. PubMed ID: 10932924
    [No Abstract]   [Full Text] [Related]  

  • 13. Deterioration in renal function associated with fibrate therapy.
    Goffin E; Devuyst O; Pirson Y
    Clin Nephrol; 2001 Jun; 55(6):490. PubMed ID: 11434364
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hypolipidemic agents].
    Gómez Gerique JA
    Rev Clin Esp; 1991 Apr; 188(6):271-2. PubMed ID: 1780525
    [No Abstract]   [Full Text] [Related]  

  • 15. [How to prescribe and monitor treatment with hypolipidemic drugs].
    Basdevant A; Soffer M
    Rev Prat; 1983 Nov; 33(54):2967-71. PubMed ID: 6665480
    [No Abstract]   [Full Text] [Related]  

  • 16. Lipid-lowering drugs and changes to diet can make a difference.
    TreatmentUpdate; 2001 Aug; 13(4):7-9. PubMed ID: 11590981
    [No Abstract]   [Full Text] [Related]  

  • 17. [Why does adequate tolerance of a lipid-lowering agent play such an important role?].
    Mutschler E
    Fortschr Med; 1990; 108 Spec No 1():54-5. PubMed ID: 2245962
    [No Abstract]   [Full Text] [Related]  

  • 18. [Can we really reach our goals? Arguments for aggressive lipid lowering].
    Internist (Berl); 1999 Sep; 40(9 Suppl Argumente):1-8. PubMed ID: 10528586
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug treatment of lipid disorders.
    Broeders N; Knoop C; Abramowicz D
    N Engl J Med; 1999 Dec; 341(26):2020-1. PubMed ID: 10617402
    [No Abstract]   [Full Text] [Related]  

  • 20. [Practice guidelines--disorders of lipid metabolism. From recommendations to therapy of disorders of lipid metabolism by the Drug Committee of the German Medical Society. Drug Committee of the German Medical Society].
    Z Arztl Fortbild Qualitatssich; 2000 Jan; 94(1):61-4. PubMed ID: 10721166
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.